ArticleAmerican journal of preventive medicine2026
Lifetime Nonprescribed Opioid Use by Sex, Race/Ethnicity, and Sexual Identification Among U.S. High-School Students.
Article in American journal of preventive medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
introductionThe opioid crisis continues to be a public health concern. Little attention has been given to the relationship between the intersectional heterogeneity of racial/ethnic identification and sexual/gender minority status on opioid use among U.S. high-school students and how this risk varies by sex.
methodsData were derived from the national 2023 Youth Risk Behavior Survey (N=20,103) for U.S. high-school students. This study estimated the odds of lifetime nonprescribed opioid use (n=2,465) among exposures race/ethnicity and sexual/gender minority status and stratified by sex.
resultsCompared with heterosexual White adolescents, all categories of sexual/gender minority and race/ethnicity (White [AOR=2.23, 95% CI=1.57, 3.14], Hispanic/Latino [AOR=3.29, 95% CI=2.09, 5.19], Black [AOR=2.68, 95% CI=1.87, 3.85], and other [AOR=2.84, 95% CI=1.88, 4.31]) had elevated odds of lifetime nonprescribed opioid use, which varied by sex. Compared with heterosexual White girls, the strongest association was among sexual/gender minority Hispanic/Latino girls (AOR=3.26, 95% CI=1.98, 3.36), followed by sexual/gender minority and Black (AOR=2.53, 95% CI=1.70, 3.76). Compared with heterosexual White boys, the strongest association was among sexual/gender minority racially other (AOR=4.58, 95% CI=2.38, 8.82), followed by sexual/gender minority Hispanic/Latino (AOR=3.23, 95% CI= 1.68, 6.19). Compared with heterosexual and White, heterosexual Black boys had elevated odds of opioid use, whereas no difference was found among heterosexual Black girls.
conclusionsThis study highlights the heterogeneity of opioid use within intersectional adolescent groups and that sex, race/ethnicity, and sexual identity need to be examined as subsets of the population through an intersectional lens. Interventions tailored with an intersectional approach are needed to reduce structural stigma and promote targeted opioid-use initiation reductions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.